SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fukagawa M.)
 

Search: WFRF:(Fukagawa M.) > Active Vitamin D Us...

Active Vitamin D Use and Fractures in Hemodialysis Patients : Results from the International DOPPS

Komaba, Hirotaka (author)
Tokai University School of Medicine,Tokai University
Zhao, Junhui (author)
Arbor Research Collaborative for Health
Karaboyas, Angelo (author)
Arbor Research Collaborative for Health
show more...
Yamamoto, Suguru (author)
Niigata University
Dasgupta, Indranil (author)
University Hospitals Birmingham,University of Warwick
Hassan, Mohamed (author)
Abu Dhabi Health Services Company
Zuo, Li (author)
Peking University
Christensson, Anders (author)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Skåne University Hospital
Combe, Christian (author)
Centre Hospitalier Universitaire de Bordeaux
Robinson, Bruce M. (author)
University of Michigan
Fukagawa, Masafumi (author)
Tokai University School of Medicine
show less...
 (creator_code:org_t)
2023
2023
English 9 s.
In: Journal of Bone and Mineral Research. - 0884-0431. ; 38:11, s. 1577-1585
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Active vitamin D is commonly used to control secondary hyperparathyroidism in dialysis patients, but it is unknown whether active vitamin D directly improves bone strength, independently of its ability to suppress parathyroid hormone (PTH). We analyzed the association between the prescription of active vitamin D and incidence of any fracture and hip fracture in 41,677 in-center hemodialysis patients from 21 countries in phases 3 to 6 (2005 to 2018) of the Dialysis Outcomes and Practice Patterns Study (DOPPS). We used Cox regression, adjusted for PTH and other potential confounders, and used a per-protocol approach to censor patients at treatment switch during follow-up. We also used a facility preference approach to minimize confounding by indication. Overall, 55% of patients were prescribed active vitamin D at study enrollment. Event rates (per patient-year) were 0.024 for any fracture and 0.010 for hip fracture. The adjusted hazard ratio (95% confidence interval) comparing patients prescribed versus not prescribed active vitamin D was 1.02 (0.90 to 1.17) for any fracture and 1.00 (0.81 to 1.23) for hip fracture. In the facility preference approach, there was no difference in fracture rate between facilities with higher versus lower active vitamin D prescriptions. Thus, our results do not suggest a PTH-independent benefit of active vitamin D in fracture prevention and support the current KDIGO guideline suggesting the use of active vitamin D only in subjects with elevated or rising PTH. Further research is needed to determine the role of active vitamin D beyond PTH control.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Ortopedi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Orthopaedics (hsv//eng)

Keyword

ACTIVE VITAMIN D
BONE METABOLISM
FRACTURE
HEMODIALYSIS
PARATHYROID HORMONE
SECONDARY HYPERPARATHYROIDISM

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view